February 2, 2017 by Chain Drug Review
Fred's, Michael Bloom, Rite Aid, Walgreens Boots Alliance, Walgreens-Rite Aid merger
Business, Featured Articles, Leading Headlines, Retail News
MEMPHIS, Tenn. — Sales continued to slide at Fred’s Inc., as the discount and pharmacy retailer reported decreases for its fiscal 2016 fourth quarter and full year and January 2017. Fred’s said Thursday that January sales totaled $148.1 million, down 5.6% from $156.9 million a year earlier. Same-store sales for the month fell 4.8%, compared
January 31, 2017 by Chain Drug Review
Cerberus Capital Management, Federal Trade Commission, Fred's, Fred's Pharmacy, Rite Aid, Walgreens Boots Alliance, Walgreens-Rite Aid merger
Business, Featured Articles, Leading Headlines, Retail News
MEMPHIS, Tenn. — Fred’s Inc. has reaffirmed its $950 million deal to buy 865 Rite Aid stores to be divested for antitrust clearance of Walgreens Boots Alliance’s pending acquisition of Rite Aid Corp. Fred’s said late Monday that “the asset purchase agreement it entered into on Dec. 19, 2016, with Walgreens and Rite Aid remains
January 30, 2017 by Chain Drug Review
Rite Aid, Walgreens Boots Alliance, Walgreens-Rite Aid merger
Business, Featured Articles, Leading Headlines, Retail News
DEERFIELD, Ill., CAMP HILL, Pa. — Walgreens Boots Alliance (WBA) Inc. and Rite Aid Corp. have agreed to extend the end date for their merger deal and lower the offer price. The companies said Monday that the deal end date has been moved to July 31 — after the previous extension expired this past Friday
January 27, 2017 by CDR Blog and Chain Drug Review
Cerberus Capital Management, Federal Trade Commission, Fred's, Rite Aid, Walgreens, Walgreens Boots Alliance, Walgreens-Rite Aid merger
CDR Blog
As the clock winds down on today’s deal end date for the Walgreens-Rite Aid merger, a report of a new potential player has emerged. Citing anonymous sources, the New York Post reported Friday that private equity firm Cerberus Capital Management has expressed interest in the 865 Rite Aid stores that Walgreens Boots Alliance and Rite
January 26, 2017 by Chain Drug Review
Fred's, Rite Aid, Stefano Pessina, Walgreens Boots Alliance, Walgreens-Rite Aid merger, WBA's annual shareholders meeting
Business, Featured Articles, Leading Headlines, Retail News
NEW YORK — Walgreens Boots Alliance (WBA) is still negotiating with the Federal Trade Commission to gain antitrust clearance for its $17 billion deal to acquire Rite Aid Corp., WBA executive vice chairman and chief executive officer Stefano Pessina said at the company’s annual shareholders meeting. “The FTC is doing its job. The process is
January 20, 2017 by CDR Blog and Chain Drug Review
Federal Trade Commission, Fred's, Rite Aid, Rite Aid shares, Walgreens, Walgreens Boots Alliance, Walgreens-Rite Aid merger
CDR Blog
Trading of Rite Aid shares was briefly halted on the New York Stock Exchange on Friday when the stock price sank following published reports that the Federal Trade Commission is iffy about antitrust concessions for approval of the Walgreens-Rite Aid merger. Rite Aid shares suspended trading after dropping 18% but resumed minutes later, TheStreet.com reported.
January 16, 2017 by David Pinto and Chain Drug Review
Albertsons, America’s drug chains, Bob Miller, CVS Health, David Pinto, Doug McMillon, George Riedl, Helena Foulkes, John Standley, Larry Merlo, Ornella Barra, Rite Aid, Stefano Pessina, Walgreens, Walgreens Boots Alliance, Walmart
2017, Issue 01-16-2017, Issues, Opinion
Going into the new year, several key personnel questions await answers, foremost among them the age-old problem of determining who, in 2017, will emerge as the most influential senior staffers at America’s drug chains. The determination is made more difficult by the fact that, as of this writing, Walgreens’ acquisition of Rite Aid remains unresolved.
January 13, 2017 by Chain Drug Review
Ken Martindale, KidCents, Rite Aid, Rite Aid Foundation
Retail News
CAMP HILL, Pa. — The Rite Aid Foundation said 219 new nonprofit groups focused on improving children’s health and wellness have joined its KidCents program. Each of the new charities, selected by Rite Aid associates and representing the communities served by the drug chain, will receive a $5,000 KidCents grant for their efforts and participation
January 5, 2017 by Chain Drug Review
Fred's, Rite Aid, Stefano Pessina, Walgreens Boots Alliance, Walgreens-Rite Aid merger, WBA
Business, Featured Articles, Leading Headlines, Retail News
DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) edged past Wall Street’s adjusted earnings per share forecast in its fiscal 2017 first quarter despite declined sales and net income. WBA also reported Thursday that it’s still working to finalize its $17 billion deal to acquire Rite Aid Corp. and continues to expect to complete the transaction
January 2, 2017 by Greg Jacobson and Chain Drug Review
Alex Gourlay, Brian Tanquilut, Fred's, Jefferies LLC, Rite Aid, Stefano Pessina, Walgreens Boots Alliance, Walgreens-Rite Aid merger
2017, Issue 01-02-2017, Issues, News
NEW YORK — Walgreens Boots Alliance Inc. (WBA) and Rite Aid Corp. have agreed to sell 865 Rite Aid stores and related assets to Fred’s Inc. for $950 million in cash. The deal is subject to approval by the Federal Trade Commission as well as approval and completion of the pending WBA acquisition of Rite
January 2, 2017 by Jeffrey Woldt and Chain Drug Review
Fred's, Jeffrey Woldt, John Standley, Ken Martindale, Mike Bloom, Rite Aid, sale of the Rite Aid stores to Fred’s, Stefano Pessina, Walgreens Boots Alliance, Walgreens-Rite Aid merger
2017, Issue 01-02-2017, Issues, Opinion
The agreement struck last month for the sale of 865 Rite Aid Corp. drug stores to Fred’s Inc. is a momentous development for those companies, as well as Walgreens Boots Alliance, which after 14 months is still working to finalize the acquisition of Rite Aid. The $950 million all-cash deal will bring Fred’s stores and
January 2, 2017 by David Pinto and Chain Drug Review
Albertsons, chain drug industry, chain drug retailing, CVS, David Pinto, Fred's, mass retailing business, Rite Aid, Target, Walgreens Boots Alliance, Walmart
2017, Issue 01-02-2017, Issues, Opinion
The new year is finally here. On balance, 2016 was a year best forgotten. Very few events of a positive nature will be remembered. On the other hand, many unsettling moments would best be reviewed at another time — if at all. As 2017 dawns, several important questions remain to be resolved, a few of
December 28, 2016 by Chain Drug Review
Alden Golden Capital, Fred's, Rite Aid, Walgreens Boots Alliance
Business, Featured Articles, Leading Headlines, Retail News
MEMPHIS, Tenn. — Fred’s Inc. has adopted a shareholder rights plan, also known as a “poison pill,” after a hedge fund recently became the company’s single largest shareholder. Fred’s said Tuesday its board instituted the shareholder rights plan after observing “unusual and substantial activity in the company’s shares.” The discount and pharmacy retailer noted that
December 23, 2016 by CDR Blog and Chain Drug Review
Brian Tanquilut, Fred's, Jefferies, Mike Bloom, Rite Aid, Walgreens Boots Alliance, Walgreens-Rite Aid merger
CDR Blog
Though Fred’s name came up in the buzz surrounding the Walgreens-Rite Aid merger talks with the FTC, the Southeastern retailer’s move to buy 865 Rite Aid stores for $950 million in cash from Walgreens Boots Alliance (WBA) still was surprising. After all, not even two weeks ago, Fred’s reported poor third-quarter results (including a net